Genetic and Epigenetic Regulation of PD-1 Expression.
Alexander P R BallyJames W AustinJeremy M BossPublished in: Journal of immunology (Baltimore, Md. : 1950) (2016)
The inhibitory immune receptor programmed cell death-1 (PD-1) is intricately regulated. In T cells, PD-1 is expressed in response to most immune challenges, but it is rapidly downregulated in acute settings, allowing for normal immune responses. On chronically stimulated Ag-specific T cells, PD-1 expression remains high, leading to an impaired response to stimuli. Ab blockade of PD-1 interactions during chronic Ag settings partially restores immune function and is now used clinically to treat a variety of devastating cancers. Understanding the regulation of PD-1 expression may be useful for developing novel immune-based therapies. In this review, the molecular mechanisms that drive dynamic PD-1 expression during acute and chronic antigenic stimuli are discussed. An array of cis-DNA elements, transcription factors, and epigenetic components, including DNA methylation and histone modifications, control PD-1 expression. The interplay between these regulators fine-tunes PD-1 expression in different inflammatory environments and across numerous cell types to modulate immune responses.
Keyphrases
- poor prognosis
- dna methylation
- immune response
- transcription factor
- binding protein
- long non coding rna
- liver failure
- stem cells
- single cell
- drug induced
- toll like receptor
- mesenchymal stem cells
- young adults
- inflammatory response
- mass spectrometry
- respiratory failure
- quantum dots
- extracorporeal membrane oxygenation
- cell free
- circulating tumor
- circulating tumor cells